Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid
Document Type
Article
Publication Date
1-1-2018
Publication Title
Alzheimer Disease & Associated Disorders
Volume
32
Issue
3
First page number:
255
Last page number:
257
Abstract
Brain changes realted to Alzeimer's disease (AD) exist years before manifestation of any cognitive decline. Mild cognitive impairment (MCI) is impairment in cognition with preserved independence and functional abilities. MCI is considered a risk factor for dementia, however, not all MCI conditions are due to AD pathology.
Keywords
Alzheimer's disease, Biomarkers, Cortical thickness, Volumetric, CSF
Language
eng
Repository Citation
Ghazi-Saidi, L.,
Walsh, R. R.,
Shan, G.,
Banks, S. J.
(2018).
Biomarkers of Cognitive Impairment: Brain Cortical Thickness, Volumetrics, and Cerebrospinal Fluid.
Alzheimer Disease & Associated Disorders, 32(3),
255-257.
http://dx.doi.org/10.1097/WAD.0000000000000226